103 related articles for article (PubMed ID: 3518711)
1. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. II. Production and characterization of an anti-MIF antibody.
Fahlbusch B; Metzner G; Schumann I; Tittel R
Biomed Biochim Acta; 1986; 45(3):371-84. PubMed ID: 3518711
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
Fahlbusch B; Tittel R
Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
Fahlbusch B; Schumann I
Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
[TBL] [Abstract][Full Text] [Related]
4. A nonspecific inhibitor of macrophage migration in cell-free ascites of rat Zajdela hepatoma. II. Biochemical characterization and purificaton.
Fahlbusch B; Zschiesche W
Acta Biol Med Ger; 1981; 40(6):793-800. PubMed ID: 7034428
[TBL] [Abstract][Full Text] [Related]
5. The production of anti-guinea pig lymphokine antibody.
Yoshida T; Bigazzi PE; Cohen S
J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
[TBL] [Abstract][Full Text] [Related]
6. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
Scott DM; McConnell I; Agomo P; Lachmann PJ
Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of a monoclonal antibody (1C5) to human migration inhibitory factor (MIF).
Burmeister G; Tarcsay L; Sorg C
Immunobiology; 1986 Jul; 171(4-5):461-74. PubMed ID: 3527953
[TBL] [Abstract][Full Text] [Related]
8. Studies on guinea-pig macrophage migration inhibitory factor (MIF). I. Glycoprotein nature and net charge.
Kotkes P; Pick E
Clin Exp Immunol; 1979 Sep; 37(3):532-9. PubMed ID: 228883
[TBL] [Abstract][Full Text] [Related]
9. Partial purification and chemical characterization of macrophage cytotoxicity factor (MCF, MAF) and its separation from migration inhibitory factor (MIF).
Kniep EM; Domzig W; Lohmann-Matthes ML; Kickhöfen B
J Immunol; 1981 Aug; 127(2):417-22. PubMed ID: 6166671
[TBL] [Abstract][Full Text] [Related]
10. Characterization of tilorone-induced mouse migration inhibitory factor by affinity chromatography and isoelectric focusing.
Fahlbusch B; Zschiesche W; Römer W
Acta Biol Med Ger; 1981; 40(2):147-52. PubMed ID: 7023160
[TBL] [Abstract][Full Text] [Related]
11. Anti-lymphokine antibody. II. Specificity of biological activity.
Kuratsuji T; Yoshida T; Cohen S
J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
[TBL] [Abstract][Full Text] [Related]
12. Role of macrophage migration inhibitory factor (MIF) in allergic and endotoxin-induced airway inflammation in mice.
Korsgren M; Källström L; Uller L; Bjerke T; Sundler F; Persson CG; Korsgren O
Mediators Inflamm; 2000; 9(1):15-23. PubMed ID: 10877450
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis.
Sakai Y; Masamune A; Satoh A; Nishihira J; Yamagiwa T; Shimosegawa T
Gastroenterology; 2003 Mar; 124(3):725-36. PubMed ID: 12612911
[TBL] [Abstract][Full Text] [Related]
14. Studies on human migration inhibitory factor: characterization of three molecular species.
Weiser WY; Greineder DK; Remold HG; David JR
J Immunol; 1981 May; 126(5):1958-62. PubMed ID: 7012240
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock.
Calandra T; Bucala R
J Inflamm; 1995-1996; 47(1-2):39-51. PubMed ID: 8913928
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure.
Nishihira J; Kuriyama T; Nishino H; Ishibashi T; Sakai M; Nishi S
Biochem Mol Biol Int; 1993 Dec; 31(5):841-50. PubMed ID: 8136702
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor expression in ovarian cancer.
Agarwal R; Whang DH; Alvero AB; Visintin I; Lai Y; Segal EA; Schwartz P; Ward D; Rutherford T; Mor G
Am J Obstet Gynecol; 2007 Apr; 196(4):348.e1-5. PubMed ID: 17403417
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
19. Partial characterization of murine migration inhibitory factor (MIF).
Kühner AL; David JR
J Immunol; 1976 Jan; 116(1):140-5. PubMed ID: 1107423
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
